VALBIOTIS |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.125 EUR | -2.48% |
|
-10.33% | -17.50% |
| 26/04 | Valbiotis SA Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 03/04 | Valbiotis: launch of Valbiotis PRO Cholesterol in May | CF |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VALBIOTIS | Bio Therapeutic Drugs | -2.48% | -10.33% | -17.50% | +11.79% | +3.12% | 7.25Cr |  | |  |
Technical Rankings Surperformance
- Stock Market
- Equities
- ALVAL Stock
- Charts VALBIOTIS
- Comparison Chart
